Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

CD44 and hematologic malignancies.

Jianing Liu¹, Guosheng Jiang

¹Department of Hemato-oncology, Institute of Basic Medicine, Shandong Academy of Medical Science, Jinan 250062, Shandong, China.

Cellular & Molecular Immunology

|November 10, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026

Same author

REACT (Real-world Emulated Clinical Trials): A Framework for Drug Repurposing Applied to Osteoporotic Fractures.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026

Same author

Optical communication based on tunable intensity vortex arrays.

Optics express·2026

Same author

Electrical Bandgap Evolution and Carrier-Induced Transport Regimes in Ultrathin PtSe<sub>2</sub>.

Nano letters·2026

Same author

Chromosome-level genome and transcriptome analysis of <i>Trichophyton verrucosum</i> reveals pathogenicity mechanisms and antifungal response.

Virulence·2026

Same author

Nutritional prehabilitation in patients with head and neck cancer: an evidence mapping analysis.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Same journal

FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease.

Cellular & molecular immunology·2026

Same journal

Targeting SPP1 requires moving beyond ligand blockade.

Cellular & molecular immunology·2026

Same journal

USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation.

Cellular & molecular immunology·2026

Same journal

Itaconate induces noncanonical AIM2-dependent PANoptosis in sepsis.

Cellular & molecular immunology·2026

Same journal

EZH2: an epigenetic governor of T-cell Ca<sup>2+</sup> homeostasis.

Cellular & molecular immunology·2026

Same journal

Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells.

Cellular & molecular immunology·2026

See all related articles

CD44 expression is linked to blood cancer progression. Targeting CD44 with monoclonal antibodies may offer a new differentiation therapy for leukemia, promoting leukemic blast maturation.

Area of Science:

Hematology
Oncology
Immunology

Background:

CD44 upregulation is observed in certain hematological malignancies.
CD44 expression correlates with cancer metastasis and patient prognosis.

Purpose of the Study:

To review the role of CD44 in hematological malignancies.
To explore the potential of anti-CD44 monoclonal antibodies in leukemia differentiation therapy.

Main Methods:

Review of existing literature on CD44 expression and function.
Analysis of studies investigating CD44 ligation by monoclonal antibodies.
Discussion of therapeutic strategies targeting CD44.

Main Results:

CD44 ligation with specific monoclonal antibodies can induce terminal differentiation in some leukemic blast subtypes.

Related Experiment Videos

This suggests a potential mechanism for targeted cancer therapy.

Conclusions:

CD44 is a promising therapeutic target for hematological malignancies.
Anti-CD44 differentiation therapy presents a viable strategy for leukemia treatment.